Injection-site residues - Scientific guideline

VeterinaryScientific guidelines

Greek is available via eTranslation, the European Commission's machine translation service.

Translate to Greek | Important information about machine translation

This guidance addresses the assessment of potential consumer risk from veterinary drug residues remaining at intramuscular and subcutaneous injection sites and the elaboration of appropriate pre-slaughter withdrawal periods.

Keywords: Injection site residues, withdrawal periods

Current effective version

Adopted guideline on injection site residues - Revision 1

Adopted Reference Number: EMA/CVMP/SWP/185470/2004 Rev.1 Legal effective date:

English (EN) (397.49 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Document history

Adopted guideline on injection site residues - Revision 1

Adopted Reference Number: EMA/CVMP/SWP/185470/2004 Rev.1 Legal effective date:

English (EN) (397.49 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Overview of comments received on the guideline on injection site residues (EMA/CVMP/SWP/185470/2004) - Revision 1

Reference Number: EMA/CVMP/SWP/11010/2022

English (EN) (191.03 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Draft guideline on injection site residue - Revision 1

Draft: consultation closed Consultation dates: to Reference Number: EMA/CVMP/SWP/185470/2004 Rev.1

English (EN) (429.32 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά:
Προβολή

Guideline on injection site residues - First version

Adopted Reference Number: EMEA/CVMP/542/03-FINAL Legal effective date:

English (EN) (109.64 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά: Τελευταία ενημέρωση:
Προβολή

Overview of comments received on draft guideline on injection site residues (EMEA/CVMP/542/03-FINAL)

Reference Number: EMEA/CVMP/209865/2004

English (EN) (110.09 KB - PDF)

Δημοσιεύθηκε για πρώτη φορά: Τελευταία ενημέρωση:
Προβολή

Share this page